We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$5.31M
(-1.5%)
Cap. Flow
-$33M
Cap. Flow
% of AUM
-9.71%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$10.1M |
| 2 |
Vale
VALE
|
+$2.39M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.33M |
| 4 |
Coca-Cola
KO
|
+$2.2M |
| 5 |
Wells Fargo
WFC
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$13.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$7.85M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$6.97M |
| 4 |
Logitech
LOGI
|
+$5.93M |
| 5 |
UBS Group
UBS
|
+$5.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.45% |
| 2 | Technology | 13.37% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 10.95% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Consolidated Edison
ED
$40.4B
| $37.9K | 0.01% |
525
-361
| -41% | -$28K |
|
477
Paychex
PAYX
$41.4B
| $37.9K | 0.01% |
407
+390
| +2,294% | +$34.6K |
|
478
RTX Corp
RTX
$289B
| $37.4K | 0.01% |
523
+495
| +1,768% | +$32.5K |
|
479
Nokia
NOK
$50.7B
| $37K | 0.01% |
9,468
| – | – |
|
480
Lockheed Martin
LMT
$132B
| $36.9K | 0.01% |
104
-3,903
| -97% | -$1.43M |
|
481
Virgin Galactic
SPCE
$329M
| $35.6K | 0.01% |
75
-75
| -50% | -$35K |
|
482
VF Corp
VFC
$5.88B
| $35.5K | 0.01% |
+416
| New | +$33.2K |
|
483
BridgeBio Pharma
BBIO
$16.1B
| $35.2K | 0.01% |
+495
| New | +$23.9K |
|
|
ARNA
484
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $34.4K | 0.01% |
448
-87
| -16% | -$6.52K |
|
485
Cytokinetics
CYTK
$10.9B
| $34.1K | 0.01% |
+1,642
| New | +$30K |
|
486
Crane NXT
CXT
$2.97B
| $34.1K | 0.01% |
1,264
-380
| -23% | -$8.37K |
|
487
Analog Devices
ADI
$179B
| $34K | 0.01% |
230
-28
| -11% | -$3.71K |
|
|
SAGE
488
DELISTED
Sage Therapeutics
SAGE
| $33.7K | 0.01% |
390
+384
| +6,400% | +$28.3K |
|
489
Hudbay
HBM
$10.1B
| $33.6K | 0.01% |
+4,800
| New | +$27.1K |
|
490
Microchip Technology
MCHP
$40.7B
| $33.6K | 0.01% |
486
-64
| -12% | -$3.98K |
|
|
CYPH
491
Cypherpunk Technologies Inc
CYPH
$66.6M
| $32.5K | 0.01% |
+1,446
| New | +$27.5K |
|
492
Applied Materials
AMAT
$398B
| $31.4K | 0.01% |
364
+11
| +3% | +$813 |
|
493
Lam Research
LRCX
$373B
| $31.2K | 0.01% |
660
-30,260
| -98% | -$1.27M |
|
494
Ocular Therapeutix
OCUL
$1.85B
| $31K | 0.01% |
+1,496
| New | +$22.2K |
|
495
Blue Bird Corp
BLBD
$2.36B
| $30.9K | 0.01% |
1,691
| – | – |
|
|
CLDR
496
DELISTED
Cloudera, Inc.
CLDR
| $30.6K | 0.01% |
2,198
| – | – |
|
|
PCN
497
PIMCO Corporate & Income Strategy Fund
PCN
$873M
| $29.3K | 0.01% |
1,700
| – | – |
|
498
Alaunos Therapeutics
TCRT
$4.59M
| $28.3K | 0.01% |
+75
| New | +$29.8K |
|
499
LyondellBasell Industries
LYB
$19.5B
| $27.4K | 0.01% |
299
| – | – |
|
|
APHA
500
DELISTED
Aphria Inc. Common Shares
APHA
| $25.9K | 0.01% |
3,741
-740
| -17% | -$4.62K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2020 Portfolio in Review
As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.
- Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
- Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
- Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
- Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
- Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
- Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
- Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.
Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.